Ocular Surface

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Preeya K. Gupta, MD, discusses Vevye’s positive impact on the signs and symptoms of dry eye disease.

Ophthalmologists must work with oncologists to understand and mitigate ocular surface adverse events caused by oncologic therapeutics, according to a presentation at Real World Ophthalmology.

What a wild ride these last 10 years or so have been.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

ATLANTA — New molecularly targeted cancer medications can cause ocular surface and retinal toxicities, according to Joseph P. Shovlin, OD, FAAO, at SECO 2024.

Treatment with stem cells may be among the considerations in patients with ocular surface disease who have not responded to traditional therapy, according to a speaker at the Twin Cities Ocular Surface Disease Symposium.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

Bausch + Lomb has announced the U.S. commercial launch of Miebo, a perfluorohexyloctane ophthalmic solution designed to treat signs and symptoms of dry eye disease by directly targeting tear evaporation.

MARCO ISLAND, Fla. — In this Healio Video Perspective, Alice T. Epitropoulos, MD, FACS, shares pearls for the detection and treatment of neurotrophic keratitis she presented at the Women in Ophthalmology Summer Symposium.